You just read:

Resverlogix Hosts Symposium to Discuss the Role of BET-inhibition in Modifying Cardiovascular Risk at the ESC Congress in Rome, Italy

News provided by

Resverlogix Corp.

29 Aug, 2016, 11:03 ET